middle.news
Vitrafy Builds US Blood Network as FDA Device Listing Nears
8:17am on Wednesday 28th of October, 2026 AEDT
•
Life Sciences
Read Story
Vitrafy Builds US Blood Network as FDA Device Listing Nears
8:17am on Wednesday 28th of October, 2026 AEDT
Key Points
Third US civilian blood partnership signed with Versiti
Exposure to approximately 17% of US civilian blood collection sites
Charter Medical agreement opens US cell and gene therapy channel
FDA medical device listing remains planned for end-2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE